Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer

Open access

Abstract

Abstract To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa patients with SVI, which is known as a factor of very high-risk PCa. Preoperative clinical variables and postoperative pathological variables were evaluated as predictors of biochemical recurrence (BCR) with a multivariate logistic regression. Immune cell infiltration including the CD8-positive cell (CD8+ cell) and CD204-positive M2-like macrophage (CD204+ cell) was investigated by immunohistochemistry. The cumulative incidence and risk of BCR were assessed with a Kaplan–Meier analysis and competing risks regression. A higher CD8+ cell count in the SVI area significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). A lower CD204+ cell count in the SVI area also significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). Furthermore, the combination of the CD8+ and CD204+ cell infiltration ratio of the SVI area to the main tumor area was a significant factor for BCR in the patients with the PCa with SVI (p = 0.001). In PCa patients with SVI, the combination of CD8+ and CD204+ cell infiltration is useful to predict the prognosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-01900-4

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The Kaplan–Meier analysis of the recurrence-free survival of patients with seminal vesicle invasion according to the CD8+ cell in the main tumor area (a, p = 0.401) and seminal vesicle invasion area (b, p = 0.004) and the CD204+ cell in the main tumor area (c, p = 0.042) and seminal vesicle invasion area (d, p = 0.004). Solid square means higher density, and dotted square means lower density.
Figure 1 The Kaplan–Meier analysis of the recurrence-free survival of patients with seminal vesicle invasion according to the CD8+ cell in the main tumor area (a, p = 0.401) and seminal vesicle invasion area (b, p = 0.004) and the CD204+ cell in the main tumor area (c, p = 0.042) and seminal vesicle invasion area (d, p = 0.004). Solid square means higher density, and dotted square means lower density.CC BY · PubMed Central
Figure 2 The Kaplan–Meier analysis of the recurrence-free survival of patients with seminal vesicle invasion according to the combination of the CD8+ and CD204+ cell. No significant difference between four groups was observed in the main tumor area (a, p = 0.150). However, a significant difference between four groups was observed in the seminal vesicle invasion area (b, p < 0.001). Group II, which included patients with the higher CD8+ cell count and the lower CD204+ cell count, had the most favorable outcome among the four groups. The 6-year progression free survival (PFS) rate of Group II was 90.9%.
Figure 2 The Kaplan–Meier analysis of the recurrence-free survival of patients with seminal vesicle invasion according to the combination of the CD8+ and CD204+ cell. No significant difference between four groups was observed in the main tumor area (a, p = 0.150). However, a significant difference between four groups was observed in the seminal vesicle invasion area (b, p < 0.001). Group II, which included patients with the higher CD8+ cell count and the lower CD204+ cell count, had the most favorable outcome among the four groups. The 6-year progression free survival (PFS) rate of Group II was 90.9%.CC BY · PubMed Central
Figure 3 The Kaplan–Meier analysis of the recurrence-free survival of patients with seminal vesicle invasion according to the ratio of the CD8+ and CD204+ cells in the seminal vesicle invasion area to those in the main tumor area (SVM Score) for each tumor. A significant difference between the higher and lower SVM Score of CD8 + and CD204+ cell count was observed (CD8: p = 0.012, 4a, CD204: p = 0.037, 4b). Group I, which included patients with the higher SVM Score of CD8+ cell count and the lower SVM Score of CD204+ cell count, had the significantly favorable outcome (p = 0.002, 4c).
Figure 3 The Kaplan–Meier analysis of the recurrence-free survival of patients with seminal vesicle invasion according to the ratio of the CD8+ and CD204+ cells in the seminal vesicle invasion area to those in the main tumor area (SVM Score) for each tumor. A significant difference between the higher and lower SVM Score of CD8 + and CD204+ cell count was observed (CD8: p = 0.012, 4a, CD204: p = 0.037, 4b). Group I, which included patients with the higher SVM Score of CD8+ cell count and the lower SVM Score of CD204+ cell count, had the significantly favorable outcome (p = 0.002, 4c).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 29

Metadata

Authors
Yanai, Y., Kosaka, T., Mikami, S., Hongo, H., Yasumizu, Y., Takeda, T., Matsumoto, K., Miyauchi, J., Kitano, S., & Oya, M.
Affiliations
  • Keio University (JP)
  • Saitama Municipal Hospital (JP)
  • National Cancer Center Hospital (JP)
Corresponding author
Kosaka, Takeo
Venue
Scientific Reports
Published
2021-11-18
Volume
11
Issue
1
Pages
22495-22495
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3182507454
Cited by
28
References
30
Citations by year
2026: 2 · 2025: 8 · 2024: 8 · 2023: 4 · 2022: 6
FWCI
2.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Grants-in-Aid for Scientific Research (#18K16709, #17K11158)
  • Takeda Science Foundation
  • Japan from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from SGH foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
prostate cancer, seminal vesicle invasion, CD8+ T cells, CD204, M2 macrophages, tumor microenvironment, radical prostatectomy, biochemical recurrence, prognostic factors, immune cell infiltration, very high-risk prostate cancer
MeSH terms
Aged, Humans, Macrophages, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Prostate, Prostatectomy, Prostatic Neoplasms, Regression Analysis, Retrospective Studies, Risk, Seminal Vesicles, Incidence, Multivariate Analysis, Prostate-Specific Antigen, CD8-Positive T-Lymphocytes, Scavenger Receptors, Class A, Kaplan-Meier Estimate, Tumor Microenvironment, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer. https://app.cochat.ai/papers/10.1038/s41598-021-01900-4
The paper
Yanai, Y., Kosaka, T., Mikami, S., Hongo, H., Yasumizu, Y., Takeda, T., Matsumoto, K., Miyauchi, J., Kitano, S., & Oya, M. (2021). CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer. Scientific Reports. https://doi.org/10.1038/s41598-021-01900-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.